New Hope Against Pancreatic Cancer

A new drug extended life by nearly half a year in a clinical trial.

[Lisa Jarvis] Progress against pancreatic cancer

Every once in a while, an advance in treating cancer is so stunning that doctors get chills. Such is the case for Revolution Medicines’ pancreatic cancer therapy daraxonrasib, which in a late-stage study allowed patients with advanced disease to live twice as long as those who only received chemotherapy. That’s an astounding advance for a cancer where experimental treatments have tended to offer progress measured in days or weeks, if at all. Giving patients and their families more months of time

By The Korea Herald